Show simple item record

dc.contributor.authorFlores-Chavez, Maria 
dc.contributor.authorMerino, F J
dc.contributor.authorGarcia-Bujalance, S
dc.contributor.authorMartin-Rabadan, P
dc.contributor.authorMerino, P
dc.contributor.authorGarcia-Bermejo, I
dc.contributor.authorDelgado, A
dc.contributor.authorCuadros, J
dc.date.accessioned2020-02-03T09:00:12Z
dc.date.available2020-02-03T09:00:12Z
dc.date.issued2011-09-22
dc.identifier.citationEuro Surveill. 2011 Sep 22;16(38). pii: 19974.es_ES
dc.identifier.issn1560-7917es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9008
dc.description.abstractOne of the most important modes of transmission of Trypanosoma cruzi infection in areas where it is not endemic is vertical transmission: from mother to child. The objective of this report is to assess the efficacy of different programmes of serological screening to monitor infection with T. cruzi in pregnant Latin American women living in Madrid (Spain). To achieve this, a retrospective study was undertaken from January 2008 to December 2010 in seven hospitals in the Autonomous Community of Madrid. Serological screening programmes were classified in two main strategies: a selective one (pregnant women from Bolivia) and a universal one (pregnant women from Latin America). A total of 3,839 pregnant women were tested and the overall prevalence was 3.96%. The rate of congenital transmission was 2.6%. The current monitoring programmes have variable coverage ranging between 26% (selective screening) and 100% (universal screening). Monitoring of pregnant women from Latin America only reaches full coverage if universal screening of pregnant women is carried out at any moment of pregnancy, including at delivery. A common national regulation is necessary in order to ensure homogenous implementation of screening.es_ES
dc.description.sponsorshipMD Flores-Chavez is supported by Red de Investigación de Enfermedades Tropicales (RETIC-RICET, RD06/ 0021/0009)es_ES
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Controles_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult es_ES
dc.subject.meshChagas Disease es_ES
dc.subject.meshEnzyme-Linked Immunosorbent Assay es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInfectious Disease Transmission, Vertical es_ES
dc.subject.meshLatin America es_ES
dc.subject.meshPolymerase Chain Reaction es_ES
dc.subject.meshPopulation Surveillance es_ES
dc.subject.meshPregnancy es_ES
dc.subject.meshPregnancy Complications, Parasitic es_ES
dc.subject.meshPrevalence es_ES
dc.subject.meshRetrospective Studies es_ES
dc.subject.meshRisk Factors es_ES
dc.subject.meshSpain es_ES
dc.subject.meshTrypanosoma cruzi es_ES
dc.subject.meshYoung Adult es_ES
dc.titleSurveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010es_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID21958533es_ES
dc.format.volume16es_ES
dc.format.number38es_ES
dc.identifier.doi10.2807/ese.16.38.19974-enes_ES
dc.contributor.funderRed de Investigación Cooperativa en Enfermedades Tropicales (España)es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1560-7917es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/ese.16.38.19974-enes_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RETIC-RICET, RD06/ 0021/0009es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional